✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

CSL Ltd

Common Name
CSL
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
29,904
Ticker
CSL
Exchange
Australian Securities Exchange
Description
CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s port...

CSL's GHG Emissions Data Preview

In 2025, CSL completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, CSL has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022-2019
Total Scope 1
135,000a
133,000a
113,000a
Total Scope 2
Market-Based
151,000a
215,000a
223,000a
Location-Based
N/AN/AN/A
Total Scope 3
N/AN/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
5.7823a
5.9836a
5.6688a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=CSL&reporting_period=2025"

Verified Sources Behind CSL’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CSL's Annual Report 2025
b. CSL's Annual Report 2023

Insights into CSL's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of CSL amounted to 286,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of CSL decreased by 17.82%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

CSL's Scope 1 Emissions Over Time

2022202320242025035 k70 k105 k140 ktCO2e+9%+18%+2%
  • Total Scope 1
  • Year-over-Year Change

What are CSL's Scope 1 emissions?

In 2025, the total Scope 1 emissions of CSL were 135,000 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2024), CSL's Scope 1 emissions increased by 1.5%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are CSL's Scope 2 emissions?

In 2025, CSL reported Scope 2 greenhouse gas (GHG) emissions of 151,000 tCO₂e using the market-based method.a

Has CSL reduced its Scope 2 emissions over time?

Compared to the previous year (2024), CSL's Scope 2 emissions (Market-Based) fell by 29.77% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does CSL use for Scope 2 reporting?

In 2025, CSL reported its Scope 2 emissions using the market-based method.a

CSL's Scope 2 Emissions Over Time

2022202320242025065 k130 k195 k260 ktCO2e
  • Total Scope 2 Market-Based

Insights into CSL’s GHG Emissions Intensity Compared to Industry Peers

In 2025, CSL reported Scope 1 greenhouse gas (GHG) emissions of 135,000 tCO₂e and total revenues of USD 23,347 millions. This translates into an emissions intensity of 5.78 tCO₂e per millions USD.a

CSL's Scope 1 Emissions Intensity Compared to Peers

202002,00050,000500,000Scope 1 Emissions (tCO2e)101001,0005,00050,000Revenues (Millions of USD)3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,248Scope 1 Intensity: 10.66 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 217Scope 1 Intensity: 29.23 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 291Scope 1 Intensity: 22.02 tCO2e/$MSino BiopharmaceuticalYear: 2024Scope 1: 18,239 tCO2eRevenue: $M 3,955Scope 1 Intensity: 4.61 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,559Scope 1 Intensity: 14.99 tCO2e/$MAscendis PharmaYear: 2024Scope 1: 62 tCO2eRevenue: $M 450Scope 1 Intensity: 0.14 tCO2e/$MargenxYear: 2025Scope 1: 2,120 tCO2eRevenue: $M 4,154Scope 1 Intensity: 0.51 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,291Scope 1 Intensity: 0.04 tCO2e/$MGenmabYear: 2025Scope 1: 758 tCO2eRevenue: $M 586Scope 1 Intensity: 1.29 tCO2e/$MBiontechYear: 2024Scope 1: 2,405 tCO2eRevenue: $M 2,863Scope 1 Intensity: 0.84 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MSamsung BiologicsYear: 2024Scope 1: 71,972 tCO2eRevenue: $M 3,099Scope 1 Intensity: 23.22 tCO2e/$MBeOne MedicinesYear: 2024Scope 1: 3,547 tCO2eRevenue: $M 3,810Scope 1 Intensity: 0.93 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MUcbYear: 2025Scope 1: 22,194 tCO2eRevenue: $M 9,101Scope 1 Intensity: 2.44 tCO2e/$MCSLYear: 2025Scope 1: 135,000 tCO2eRevenue: $M 23,347Scope 1 Intensity: 5.78 tCO2e/$M

How does CSL's GHG emissions intensity compare to its peers?

In 2025, CSL reported a Scope 1 emissions intensity of 5.78 tCO₂e per millions USD. Compared to the peer group median of 3.91, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does CSL rank on GHG emissions intensity within its industry?

In 2025, CSL ranked 17 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

CSL is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to CSL's GHG Emissions Dataset?
Start 30-Day Free Trial